A growing number of Canadians who consume cannabis are obtaining it from the legal marketplace, according to data published in the journal Drug and Alcohol Dependence. Investigators affiliated with the University of Waterloo, School of Public Health Sciences surveyed nearly 5,000 Canadian adults who acknowledged having purchased cannabis flowers within the past year.

Local politicians, Health Canada officials field cannabis concerns during forum; 'All municipalities are struggling and frustrated,' says Oro-Medonte mayor

Inconsistent policies and laws among various levels of government are causing challenges and concerns when it comes to cannabis operations in municipalities.

That’s one of the messages delivered Thursday evening during a virtual information session hosted by Doug Shipley, MP for Barrie-Springwater-Oro-Medonte.

Since being elected in 2019, a year after the federal Cannabis Act came into effect, Shipley has heard a number of concerns from Oro-Medonte residents “affected” by cannabis operations in the township.

One of the arguments used all across the world against the legalisation of cannabis, that its use leads to increased cases of schizophrenia and psychosis, was dealt a blow this week. Evidence from a Canadian study shows that hospital admission for cases of cannabis-induced schizophrenia and psychosis have not risen since the Canadian government legalised adult cannabis use in 2018.  

In the study, published in the Canadian Journal of Psychiatry, researchers state that they aimed to directly address the often reported fear “that legislation might increase the burden of transient and persistent psychotic illnesses in society.”

Despite marijuana being a fast-growing industry, these cannabis stocks are buzzkills.

Although it's had its ups and downs, cannabis is forecast to be one of the fastest-growing industries over the next five years. According to cannabis-focused analytics company BDSA, global marijuana sales are projected to hit $62.1 billion by 2026, representing a doubling from the estimated $31 billion believed to have been sold globally in 2021.

However, not all marijuana stocks are going to be winners. While the industry is full of promising growth stocks, some of which are already achieving recurring profitability, the following four pot stocks, all of which have a Canadian focus, should be avoided like the plague in 2022

Although recreational cannabis has been legal in Canada for three years, the market continues to face challenges. 

Municipal bans on cannabis brick-and-mortar retailers in Canadian provinces have slowed down the growth of the industry by forcing consumers to drive long distances to municipalities that have a large number of cannabis brick-and-mortar storefronts.

The decision to ban the opening of cannabis retail stores has benefited the illicit market and we hope to see a decrease in the number of municipalities that have banned the opening of cannabis retail stores in 2022. (Click Here for full article)

The win comes only months after the initial launch by Lifeist’s wholly-owned subsidiary Cannmart Inc, and the launch of sister company CannMart Labs Inc

Lifeist Wellness Inc has announced that its Cannabis 2.0 consumer-focused house brand Roilty has won the Canadian LP Brand of the Year award at the 2021 ADCANN Awards. 

The company said the annual industry awards, which are voted on by both industry peers and the public and saw over 100,000 votes cast nationwide, celebrate the best in marketing and advertising across Canada’s cannabis industry. 

Canadian cannabis titan Tilray Inc. fell for a third straight day, surrendering much of a rally posted earlier this week after earnings that were buoyed by acquisitions and a rebranding -- moves aimed at strengthening its global reach in the face of stiff competition at home.

Canada’s marijuana-market leader is still up about 4% this week after the shares jumped 14% Monday, when it reported better-than-expected results and said it was repositioning itself as a global consumer packaged-goods “powerhouse.” Demand for its cannabis brands, craft beer and hemp products boosted profits, the company said.

Hygrovest has weathered a decline in the Canadian cannabis market with outperforming assets, but now looks to reduce risk by diversifying assets into non-cannabis sectors following approval for a broadened investment mandate at the company's AGM.

Week in Weed: Spotify versus Potify, first pot shop at a Canadian airport, and how this ancient empire's secret to success was hallucinogenic beer

A  small airport in B.C. is in the news for all the right reasons.

After marijuana was legalized in Canada, more drivers in car crashes tested positive for the drug, new research finds.

As more states legalize marijuana for recreational use, it’s become more common for people to have the drug in their  system, leaving public health officials grappling with a thorny question: What constitutes impaired driving?

For alcohol, the cutoff is uniform: A blood alcohol concentration above 0.08 percent. But there is no standard cutoff for THC, the psychoactive compound in marijuana. And even in places that do institute a cutoff, it’s unclear whether exceeding the limit constitutes impairment, experts say.